Platinib capsule specifications and current price
Pralsetinib is a targeted therapy used to treat patients with non-small cell lung cancer who have specific genetic mutations. At present, the original drug of Platinib has been launched in China, but it has not yet been included in medical insurance, so patients need to bear higher drug costs. Common packaging specifications include 100mg 60 capsules and 100mg 120 capsules. These two specifications have a large price difference in the market, which brings different economic pressures to patients.
in the country, the original drug Platinib is relatively expensive. The market price of a box of 100mg*60 tablets of Platinib is about more than 20,000 yuan. In some areas, due to differences in drug supply and sales channels, the price may even be as high as 60,000 yuan. This puts a heavy financial burden on patients who need to take medication for a long time, especially if there is no medical insurance support.

Compared with the domestic market, the price of platinib’s overseas original drug is higher. In the international market, the price of Platinib original drug in 60 capsules fluctuates greatly, usually ranging from 40,000 to more than 100,000 yuan. Depending on market pricing and availability in different countries and regions, patients may need to pay more. This puts some patients under higher financial pressure when choosing treatment, especially if they cannot afford the high cost.
Fortunately, a generic version of Platinib is already available overseas, and the price is relatively affordable. Take the 120 generic platinib drug produced in Laos as an example. Its price is about more than 3,000 yuan. The ingredients of this generic drug are similar to the original drug and its efficacy is equivalent, so it provides many patients with a more affordable treatment option. Although the price of generic drugs is lower, patients still need to pay attention to choosing formal purchasing channels when purchasing to ensure the quality and safety of the drugs.
Reference materials:https://gavreto.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)